Co-Administration Treatment in Drug-Naïve Major Depression: Exploratory Real-World Patterns and Predictors in China

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Research

Background:

• Co-administration of psychotropic medications is common in major depressive disorder (MDD).
• Patterns and predictors of co-administration in drug-naïve patients are underexplored.
• Understanding initial treatment strategies is crucial for effective MDD management.

Purpose of the Study:

• To characterize the prevalence of psychotropic medication co-administration at treatment initiation in drug-naïve MDD patients in China.
• To identify sociodemographic, clinical, and treatment-related correlates of co-administration strategies.
• To explore predictors of co-administration in this population.

Main Methods:

• Multicenter, real-world study design.
• Inclusion of 1330 drug-naïve adults with a depressive episode.
• Collection of baseline sociodemographic, clinical, and treatment data.
• Application of univariate and multivariable logistic regression analyses.

Main Results:

• Co-administration was used in 27.14% of patients, with antipsychotic augmentation being the most frequent strategy (18.87%).
• Patients receiving co-administration were more likely to be male, older, have lower education/income, and present with more severe depressive symptoms.
• Independent predictors for co-administration included sympathetic arousal (OR=1.64) and leaden paralysis (OR=1.30).

Conclusions:

• Co-administration, particularly with antipsychotics, is a frequent initial treatment for MDD in China.
• The practice appears symptom-driven, targeting specific features like sympathetic arousal and leaden paralysis.
• Findings suggest a pragmatic adaptation to clinical realities, warranting further validation in longitudinal studies.